Levosimendan use in critical care - a case series

2.50
Hdl Handle:
http://hdl.handle.net/11287/592675
Title:
Levosimendan use in critical care - a case series
Authors:
Gibson, Charles; Appelboam, Rebecca
Abstract:
Levosimendan is a calcium sensitiser that enhances myocardial contractility without increasing myocardial oxygen consumption or adversely affecting diastolic function. Whilst theoretically attractive, lack of outcome data in critically ill patients means that it is not yet established in intensive care practice. We have been using levosimendan on our Intensive Care Unit (ICU) for more than 6 years and the data presented here represents one of the largest case series on the use of levosimendan in this setting.
Citation:
Levosimendan use in critical care - a case series 2015, 3 (Suppl 1):A540 Intensive Care Medicine Experimental
Publisher:
Springer
Journal:
Intensive Care Medicine Experimental
Issue Date:
1-Oct-2015
URI:
http://hdl.handle.net/11287/592675
DOI:
10.1186/2197-425X-3-S1-A540
Additional Links:
http://www.icm-experimental.com/content/3/S1/A540
Note:
This article is freely available via Open Access from the publisher's site. Click on the 'Additional Link' above to access it from the publisher's website.
Type:
Journal Article; Poster; Presentation
Language:
en
Description:
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
ISSN:
2197-425X
Appears in Collections:
2015 RD&E publications; Intensive Care Unit (ICU)

Full metadata record

DC FieldValue Language
dc.contributor.authorGibson, Charlesen
dc.contributor.authorAppelboam, Rebeccaen
dc.date.accessioned2015-12-31T12:53:45Zen
dc.date.available2015-12-31T12:53:45Zen
dc.date.issued2015-10-01en
dc.identifier.citationLevosimendan use in critical care - a case series 2015, 3 (Suppl 1):A540 Intensive Care Medicine Experimentalen
dc.identifier.issn2197-425Xen
dc.identifier.doi10.1186/2197-425X-3-S1-A540en
dc.identifier.urihttp://hdl.handle.net/11287/592675en
dc.descriptionThis is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.description.abstractLevosimendan is a calcium sensitiser that enhances myocardial contractility without increasing myocardial oxygen consumption or adversely affecting diastolic function. Whilst theoretically attractive, lack of outcome data in critically ill patients means that it is not yet established in intensive care practice. We have been using levosimendan on our Intensive Care Unit (ICU) for more than 6 years and the data presented here represents one of the largest case series on the use of levosimendan in this setting.en
dc.language.isoenen
dc.publisherSpringeren
dc.relation.urlhttp://www.icm-experimental.com/content/3/S1/A540en
dc.rightsArchived with thanks to Intensive Care Medicine Experimentalen
dc.titleLevosimendan use in critical care - a case seriesen
dc.typeJournal Articleen
dc.typePosteren
dc.typePresentationen
dc.identifier.journalIntensive Care Medicine Experimentalen
dc.description.noteThis article is freely available via Open Access from the publisher's site. Click on the 'Additional Link' above to access it from the publisher's website.en
dc.type.versionPublisheden
All Items in RD&E Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.